| Catalog: | C0796A |
| Product Type: | Antibody |
| Size: | 0.5 mg |
| Analysis mode: | ELISA, Crystallography, SPR, NTRL |
| Species specificity: | SARS-CoV and SARS-CoV-2 |
| Host: | Human |
| Clonality: | Monoclonal |
| Isotype: | IgG |
| Clone: | CR3022 |
| Concentration: | 1.0 mg/ml |
| Storage: | –20℃ |
| Buffer: | PBS, 0.02% Proclin 300 |
| Purification method: | Affinity chromatography on a column with immobilized protein A |
| Application: | Immune Response, Infection and Inflammation, COVID-19 |
Coronavirus contains at least four structural proteins: spike protein (S), envelope protein (E), membrane protein (M) and nucleocapsid protein (N). Spike glycoprotein is a type I transmembrane glycoprotein that plays an important role in mediating viral infections and is common to all HCoV. The S protein is composed of two subunits S1 and S2. The S1 subunit binds to cell receptors through its receptor-binding domain (RBD), and then a conformational change occurs in the S2 subunit, so that the fusion peptide is inserted into the host target cell membrane. The heptad repeat 1 (HR1) region in the S2 subunit forms a homotrimeric assembly, and the surface exposes three highly conserved hydrophobic grooves on the surface-bound to the heptad repeat 2 (HR2). This six-helix bundle (6-HB) core structure is formed during the fusion process, which helps to bring the virus membrane and cell membrane close together for virus fusion and entry. Therefore, S protein is an important target protein for the development of specific drugs.
Copyright © 2025 Creative Biogene. All rights reserved.